A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. (12th June 2019)

• Record Type: Journal Article
• Authors: García‐Marco, J.; Baltasar Tello, P.; Gonzalez Garcia, E.; Ríos Herranz, E.; Ramírez Payer, Á.; Terol Castera, M.; Champ, D.; Medina Pérez, Á.; Gironella Mesa, M.; Rodríguez Fernández, A.; Muntañola Prat, A.; Suárez Cabrera, A.; Puerta Puerta, J.; Fernández Zarzoso, M.; Rodríguez Calvillo, M.; Clavel Piá, J.; Dourdil Sahun, V.; Ferrá Coll, C.; Pérez Persona, E.; Marrero Santos, C.; Forés Cachón, R.; Delgado González, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 380
• Page End: 382
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.50_2631
• Languages: English
• ISSNs: 0278-0232